Asthma therapy in pediatric patients: A systematic review of treatment with montelukast versus inhaled corticosteroids

Journal of Pediatric Health Care

Volumn 28, Issue 1, 2014, Pages 51-62

  Massingham, Kristen ^a   Fox, Shelley ^a   Smaldone, Arlene ^a  

^a Columbia University School of Nursing ^*  (United States)

Author keywords

Asthma; Inhaled corticosteroids; Montelukast

Indexed keywords

ACETIC ACID DERIVATIVE; ANTIASTHMATIC AGENT; CORTICOSTEROID; MONTELUKAST; QUINOLINE DERIVATIVE;

ASTHMA; HUMAN; INHALATIONAL DRUG ADMINISTRATION;

ACETATES; ADMINISTRATION, INHALATION; ADRENAL CORTEX HORMONES; ANTI-ASTHMATIC AGENTS; ASTHMA; HUMANS; QUINOLINES;

EID: 84890243844     PISSN: 08915245     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pedhc.2012.11.005     Document Type: Article

References (42)

1. Agertoft L., Pedersen S. Effect of long-term treatment with inhaled budesonide on adult height in children with asthma. New England Journal of Medicine 2000, 343:1064-1069.
2. Akinbami, L. J., Moorman, J. E., & Liu, X. (2011). Asthma prevalence, health care use, and mortality: United States, 2005-2009 (Report No. 32). Retrieved from. http://www.cdc.gov/nchs/data/nhsr/nhsr032.pdf.
3. Bender B.G., Ellison M.C., Gleason M., Murphy J.R., Sundstrom D.A., Szefler S.J. Minimizing attrition in a long-term clinical trial of pediatric asthma. Annals of Allergy, Asthma & Immunology 2003, 91:168-176.
4. Bisgaard H., Zielen S., Garcia-Garcia M.L., Johnston S.L., Gilles L., Menten J., Polos P., et al. Montelukast reduces asthma exacerbations in 2- to 5-year-old children with intermittent asthma. American Journal of Respiratory and Critical Care Medicine 2005, 171(4):315-322.
5. Bukstein D., Luskin A., Bernstein A. "Real-world" effectiveness of daily controller medicine in children with mild persistent asthma. Annals of Allergy, Asthma, & Immunology 2003, 90:543-549.
6. Burgess S., Sly P., Devadason S. Adherence with preventive medication in childhood asthma. Pulmonary Medicine 2010, 2011:973849.
7. Centers for Disease Control and Prevention. (2010). Asthma. Retrieved from. http://www.cdc.gov/nchs/fastats/asthma.htm.
8. Dahlén S.E. Treatment of asthma with antileukotrienes: First line or last resort therapy?. European Journal of Pharmacology 2006, 533:40-56.
9. Dahlén S.E., Dahlén B., Drazen J.M. Asthma treatment guidelines meet the real world. New England Journal of Medicine 2011, 364(18):1769-1770.
10. Ducharme F., di Salvio F. Anti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma in adults and children. Cochrane Database of Systematic Reviews 2004, 1:CD002314.
11. Fanta C. Asthma. New England Journal of Medicine 2009, 360(10):1002-1014.
12. Garcia G.M.L., Wahn U., Gilles L., Swern A., Tozzi C.A., Polos P. Montelukast, compared with fluticasone, for control of asthma among 6- to 14-year-old patients with mild asthma: The MOSAIC study. Pediatrics 2005, 116(2):360-369.
13. Harmanci K. Montelukast: Its role in the treatment of children with asthma. Journal of Therapeutics and Clinical Risk Management 2007, 3(5):885-892.
14. Kazani S., Ware J.H., Drazen J.H., Taylor D.R., Sears M.R. The safety of long-acting beta-agonists: More evidence is needed. Respirology 2010, 15(6):881-886.
15. Kelly H.W., Sternberg A.L., Lescher R., Fuhlbrigge A.L., Williams P., Zeiger R.S., Strunk R.C., et al. Effect of inhaled glucocorticoids in childhood on adult height. New England Journal of Medicine 2012, 367(10):904-912.
16. Knorr B., Franchi L.M., Bisgaard H., Vermeulen J.H., LeSouef P., Santanello N., Bratton D.L., et al. Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years. Pediatrics 2001, 108(3):e48-e58.
17. Kooi E.M.W., Schokker S., Boezen M., de Vries T.W., Vaessen-Verbern A.A.P.H., van der Molen T., Duiverman E.J. Fluticasone or montelukast for preschool children with asthma-like symptoms: Randomized controlled trial. Pulmonary Pharmacology & Therapeutics 2008, 21(5):798-804.
18. Kumar V., Ramesh P., Lodha R., Pandey R.M., Kabra S.K. Montelukast vs. inhaled low-dose budesonide as monotherapy in the treatment of mild persistent asthma: A randomized double blind controlled trial. Journal of Tropical Pediatrics 2007, 53(5):325-330.
19. Maher C.G., Sherrington C., Herbert R.D., Moseley A.M., Elkins M. Reliability of the PEDro scale for rating quality of randomized controlled trials. Physical Therapy 2003, 83(8):713-721.
20. Makino S., Ohta K., Nishima S., Morikawa A. Pharmacologic control of asthma. International Archives of Allergy and Immunology 2005, 136:14-49.
21. Maspero J.F., Duenas-Meza E., Volovitz B., Daza C.P., Kosa L., Vrijens F., Leff J.A. Evaluating long-term safety, satisfaction, and adherence with therapy. Current Medical Research and Opinion 2001, 17(2):96-104.
22. Maspero J., Guera F., Cuevas F., Gutierrez J.P., Soto-Ramos M., Anderton S., Pedersen S., et al. Efficacy and tolerability ofsalmeterol/fluticasone versus montelukast in childhood asthma: A prospective, randomized, double-blind, double dummy, parallel-group study. Clinical Therapeutics 2008, 30(8):1492-1504.
23. McQuaid E.L., Kopel S.J., Klein R.B., Fritz G.K. Medication adherence in pediatric asthma: Reasoning, responsibility, and behavior. Journal of Pediatric Psychology 2003, 28(5):323-333.
24. Moher D., Liberati A., Tetzlaff J., Altman D.G. Preferred reporting items for systematic review and meta-analyses: The PRISMA statement. PloS Medicine 2009, 6(7):e1000097. the PRISMA Group.
25. Montella S., Maglione M., De Stefano S., Manna A., Di Giorgio A., Santamaria F. Update on leukotriene receptor antagonists in preschool children wheezing disorders. Italian Journal of Pediatrics 2012, 38(1):29-46.
26. Myers T.R., Tomasio L. Asthma: 2105 and beyond. Respiratory Care 2011, 56(9):1389-1407.
27. National Asthma Education and Prevention Program. (2007). Guidelines for the diagnosis and management of asthma (NIH Publication No. 08-5846). Retrieved from. http://www.nhlbi.nih.gov/guidelines/asthma/asthsumm.pdf.
28. Osterberg L., Blaschke T. Adherence to medication. New England Journal of Medicine 2005, 353:487-497.
29. Ostrom N.D., Decotiis B.A., Lincourt W.R., Edwards L.D., Hanson K.M., Rosenzweig C., Crim C. Comparative efficacy and safety of low-dose fluticasone propionate and montelukast in children with persistent asthma. Journal of Pediatrics 2005, 147(2):213-220.
30. Pedersen S., Agertoft L., Williams-Herman D., Kuznetsova O., Reiss T., Knorr B., Wolthers O.D., et al. Placebo-controlled study of montelukast and budesonide on short-term growth in prepubertal asthmatic children. Pediatric Pulmonology 2007, 42:838-843.
31. Rachelefsky G. Inhaled corticosteroids and asthma control in children: Assessing impairment and risk. Pediatrics 2009, 123(1):353-366.
32. Santanello N.C., Davies G., Galant S.P., Pedinoff A., Sveum R., Seltzer J., Knorr B.A., et al. Validation of an asthma symptom diary for interventional studies. Archives of Diseases in Childhood 1999, 80(5):414-420.
33. Santanello N.C., Zhang J., Seidenberg B., Reiss T.F., Barber B.L. What are minimal important changes for asthma measures in a clinical trial?. European Respiratory Journal 1999, 14:23-27.
34. Sorkness C.A., Lemanske R.F.J., Mauger D.T., Boehmer S.J., Chinchilli V.M., Martinez F.D., Taussig L.M., et al. Long-term comparison of 3 controller regimens for mild-moderate persistent childhood asthma: The Pediatric Asthma Controller Trial. Journal of Allergy and Clinical Immunology 2007, 119(1):64-72.
35. Stefanovic I.M., Verona E., Cicak B., Vrsalovic R. Noeffect of fluticasone proprionate on linear growth in preschool children with asthma. Pediatrics International 2011, 53(5):672-676.
36. Szefler S.J., Baker J.W., Uryniak T., Goldman M., Silkoff P.E. Comparative study of budesonide inhalation suspension and montelukast in young children with mild persistent asthma. Journal of Allergy and Clinical Immunology 2007, 120(5):1043-1050.
37. Szefler S.J., Phillips B.R., Martinez F.D., Chinchilli V.M., Lemanske R.F., Strunk R.C., Taussig L.M., et al. Characterization of within-subject responses to fluticasone and montelukast in childhood asthma. Journal of Allergy and Clinical Immunology 2005, 115(2):233-242.
38. Taketomo C.K., Hodding J.H., Kraus D.M. Pediatric dosage handbook 2010, Lexi-Comp, Hudson, OH. 17th ed.
39. Long-term effects of budesonide or nedocromil in children with asthma. New England Journal of Medicine 2000, 343:1054-1063. The Childhood Asthma Management Program Research Group.
40. U.S. Department of Health & Human Services. (2011). Summary health statistics for U.S. children: National health interview survey, 2010 (DDH Publication No. 2012-1578). Retrieved from. http://www.cdc.gov/nchs/data/series/sr_10/sr10_250.pdf.
41. Verhagen A.P., de Vet H.C., de Bie R.A., Kessels A.G., Boers M., Bouter L.M., Knipschild P.G. The Delphi list:A criteria list for quality assessment of randomized clinical trials for conducting systematic reviews developed by Delphi consensus. Journal of Clinical Epidemiology 1998, 51(12):1235-1241.
42. Wolthers O.D. Anti-inflammatory treatment of asthma: Differentiation and trial-and-error. Acta Paediatrica 2009, 98:1237-1241.